🇺🇸 FDA
Patent

US 7414039

Interstitial therapy for immediate symptom relief and chronic therapy in interstitial cystitis

granted A61KA61K31/167A61K31/24

Quick answer

US patent 7414039 (Interstitial therapy for immediate symptom relief and chronic therapy in interstitial cystitis) held by The Regents of the University of California expires Mon Aug 14 2028 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Aug 19 2008 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 14 2028 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
22
CPC classes
A61K, A61K31/167, A61K31/24, A61K31/445, A61K31/727